Source: StreetInsider

Press Release: Glycotope : Glycotope to present platform approach for development of anti-GlycoTarget antibodies at 2024 AACR Meeting

Glycotope to present platform approach for development of anti-GlycoTarget antibodies at 2024 AACR Meeting Berlin, Germany, 08 April, 2024Â Glycotope GmbH, a biotechnology company utilizing a proprietary platform technology to developing...

Read full article »
Glycotope's Competitors | Glycotope's News | Glycotope's Financials
Stay up-to-date with the latest news on Glycotope
Est. Annual Revenue
$5.0-25M
Est. Employees
100-250
Henner Kollenberg's photo - Managing Director of Glycotope

Managing Director

Henner Kollenberg

CEO Approval Rating

90/100

Read more
Stay up-to-date with the latest news on Glycotope